BioHealth News Archive
Glaxo Is Said to Be Near a Deal for Human Genome Sciences – NYTimes.com
GlaxoSmithKline of Britain is near a deal to buy the biopharmaceutical company Human Genome Sciences on friendly terms for about $2.8 billion, potentially ending…
Read More
Wesley Blakeslee from Johns Hopkins University Tech. Transfer, “The Business Concierge to Johns Hopkins University” Video Interview at BioMaryland Booth at BIO International 2012 | Stock News Now
The Johns Hopkins Technology Transfer Office (JHTT) is the University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent,…
Read More
New Johns Hopkins center to focus on broad use of health IT tools – FierceHealthIT
Johns Hopkins University is creating a new center to help public health agencies and accountable provider or payer groups better take advantage of health…
Read More
Johns Hopkins Community helps scientists – Wes Blakeslee – Johns Hopkins Technology Transfer – YouTube
What kind of community does Johns Hopkins offer for a scientist? An excerpt of an interview in November of 2011, with Wes Blakeslee, Executive…
Read More
Human Genome Science looks to expand biotech sales jobs with new anthrax treatment
As more drug manufacturers fight for a share of the market, those with biotech sales jobs understand that their companies' success lies in its…
Read More
Venture Debt: Under-Appreciated Tool for Building Biotechs – Forbes
Cash-burning R&D-stage biotechs have big appetites for cash, which is typically addressed with an equity-based diet. It’s also supported through corporate partnerships and other…
Read More
Maryland Venture Fund names Thomas Dann as head – Washington Business Journal
Maryland has named a longtime venture capitalist to head its program for investing in startups and early-stage companies. Thomas Dann, founder and managing director…
Read More
East Coast accelerator DreamIt Ventures moving into healthcare IT
Healthcare IT has become a new priority for East Coast accelerator DreamIt Ventures with the hire of a veteran angel investor group director. Karen…
Read More
Obama Signs FDA Bill | The Scientist
President Barack Obama signed the US Food and Drug Administration Safety and Innovation Act (S. 3187) into law, reauthorizing user fees that the FDA…
Read More
Human Genome Sciences Announces Resubmission of Raxibacumab BLA to FDA
Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License…
Read More
MedStartr Offers Crowdfunding for Health IT Firms, Including Itself | Xconomy
A couple years ago, when Alex Fair was tossing around ideas on how to raise money for his new healthcare marketplace, FairCareMD, he knew…
Read More
Maryland biotech investment program sees dip from last year
Fewer prospective investors applied for a share of Maryland’s $8 million in biotechnology investment tax credits Monday morning than a year ago, state officials…
Read More
Early stage fundraising by venture firms doubles, health IT companies likely to benefit
Venture capital fundraising for early stage funds doubled in the first half of the year to $3 billion compared with the same period last…
Read More
Mass Life Sciences Center launches new accelerator – Mass High Tech Business News
The Commonwealth of Massachusetts’ quasi-public agency, the Massachusetts Life Sciences Center, has opened its 2012-2013 Accelerator Loan Program, the agency announced Monday. MLSC launched…
Read More
Maryland receives 125 applications for $8M in biotech tax credits – Washington Business Journal
Maryland received more than 125 applications on Monday for $8 million available through the state’s popular biotechnology tax credit program. The online registration for…
Read More